Organon Canada Revenue and Competitors

Kirkland, QC Canada

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Organon Canada's estimated annual revenue is currently $24.5M per year.(i)
  • Organon Canada's estimated revenue per employee is $201,000

Employee Data

  • Organon Canada has 122 Employees.(i)
  • Organon Canada grew their employee count by 8% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.2M167%N/AN/A
#2
$30.2M1501%N/AN/A
#3
$10.7M1005%$39.7MN/A
#4
$104.3M51922%N/AN/A
#5
$47.8M238N/AN/AN/A
#6
$15.5M775%N/AN/A
#7
$395.8M19697%N/AN/A
#8
$187.3M9326%N/AN/A
#9
$361.6M17996%N/AN/A
#10
$27.5M1370%N/AN/A
Add Company

Organon is a new global health company with a singular vision: to make a better and healthier every day for every woman. As the only company of its size focused on women’s health, Organon puts women at the center of everything it does, launching with a commitment to listen to women to hear —and understand —her unmet health needs and help identify solutions that are urgently needed. Organon Canada will focus on medicines that support women’s health, including contraception, fertility, and hormone therapy, and as well as medicines to treat diseases that disproportionately affect women, such as rheumatoid arthritis. Its portfolio includes over 40 medicines and products across three lines of business: Women’s Health, Biosimilars and Established Brands. Organon est une nouvelle entreprise mondiale de santé dotée d'une vision unique : faire en sorte que chaque jour soit meilleur et plus sain pour chaque femme. Seule entreprise de cette taille à se consacrer à la santé des femmes, Organon place les femmes au centre de tout ce qu'elle entreprend, en s'engageant à écouter les femmes pour connaître - et comprendre - leurs besoins de santé non comblés et aider à identifier les solutions qui s'imposent de toute urgence. Organon Canada se focalisera sur les médicaments qui soutiennent la santé des femmes, y compris la contraception, la fertilité et l'hormonothérapie, ainsi que sur les médicaments pour traiter les maladies qui affectent les femmes de manière disproportionnée, comme la polyarthrite rhumatoïde. Son portfolio comprend plus de 40 médicaments et produits répartis sur trois lignes d'activité : santé des femmes, biosimilaires et marques établies.

keywords:N/A

N/A

Total Funding

122

Number of Employees

$24.5M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Organon Canada News

2022-04-17 - Organon To Report First Quarter Results and Host Conference ...

... MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives. Organon has a portfolio...

2022-03-30 - Organon Enters into Global License Agreement to Commercialize Daré Bioscience’s XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis (BV)

"Organon will bring its commercial expertise to this ... Rahway, NJ, USA, (NYSE: MRK) known as MSD outside of the United States and Canada,...

2022-03-22 - Under the title "We Believe in Her," Organon and the African ...

Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$17.7M1223%N/A
#2
$17.7M122-38%N/A
#3
$30.3M123-2%N/A
#4
$18M124-3%N/A
#5
$41.4M1299%N/A